Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ERYtech Pharma, a specialty pharmaceutical company, has received authorization from Afssaps to open its pharmaceutical site based in Lyon, France. The activity of the site will include the export of manufactured products throughout Europe.
Subscribe to our email newsletter
This first manufacturing unit is set up, according to the European and the FDA guidelines; it allows the production of clinical batches and will allow for the manufacture of commercial batches on an industrial scale, the company said.
Yann Godfrin, co-founder and CEO of ERYtech Pharma, said: “It is exceptional, especially for a four-year company which develops innovative pharmaceutical products, to reach the best international standards of quality, reproducibility and safety. In our field, this authorization is the first one, as far as I know. This is the recognition of the skills and expertise of the team.”